Gill Pharmaceuticals Wins “Best New Pharmaceutical Aesthetics Product 2025” for ICONA H8 at the Welsh Enterprise Awards
London, UK – September 2025 – Gill Pharmaceuticals and ICONA UK are proud to announce that ICONA H8, the company’s flagship bio-revitaliser and skinbooster, has been officially recognised with the title of “Best New Pharmaceutical Aesthetics Product 2025” at the prestigious Welsh Enterprise Awards, hosted by SME News.
The Welsh Enterprise Awards celebrate businesses and innovators who are driving progress across multiple sectors in Wales and beyond. Following a comprehensive merit led research and evaluation process, Gill Pharmaceuticals was selected as the standout recipient of this award, highlighting ICONA H8’s impact on the aesthetics industry as a safe, effective, and innovative treatment.
This recognition follows an internal assessment by SME News, which commended the company’s pioneering approach and product development. The official online announcement will take place on the SME News website in November 2025, a platform which reaches over 219,000 annual web users and 6.9 million total impressions, providing further exposure for this award-winning product.
A New Benchmark in Skin Revitalisation
ICONA H8 has quickly established itself as a next-generation bio-revitaliser and skinbooster, combining 64mg of hyaluronic acid in a 2ml syringe with Vitamin C and 8 amino acids. Developed exclusively using A.R.T. Technology™ (Advanced Regenerative Technology), ICONA H8 restores hydration, improves elasticity, and supports cellular regeneration.
Fully CE marked (CE2292) and backed by a revolutionary Post-Market Surveillance (PMS) programme — the first of its kind in the world — ICONA H8 is leading the way in transparency, safety, and clinical accountability, setting a new global standard in medical aesthetics.
A Milestone Moment for Gill Pharmaceuticals
“We are absolutely thrilled that ICONA H8 has been awarded ‘Best New Pharmaceutical Aesthetics Product 2025’,” said Arthur Gill, Founder and Creator of ICONA H8. “As a Welshman born and bred, this award carries an even deeper meaning for me personally. It is a huge honour and a true recognition of the science, safety, and innovation at the heart of our work. ICONA H8 was born from our mission to create something world-class, British-developed, and uncompromising in quality. To see it acknowledged at the Welsh Enterprise Awards is a proud moment not only for myself and our team, but also for every clinic and practitioner who trusts ICONA to deliver outstanding results for their patients.”
About ICONA H8
ICONA H8 is a next-generation bio-revitaliser and skinbooster, combining 64mg of hyaluronic acid with Vitamin C and 8 amino acids. Developed with exclusive A.R.T. Technology™ and fully CE marked (CE2292), it is supported by a world-first Post-Market Surveillance (PMS) programme, setting new benchmarks for safety and performance.
About Gill Pharmaceuticals
Gill Pharmaceuticals is a British pharmaceutical and aesthetics company, founded by Arthur Gill. Through its ICONA brand, the company is committed to quality, safety, and innovation, delivering trusted results in medical aesthetics worldwide.
About the Welsh Enterprise Awards
The Welsh Enterprise Awards, hosted by SME News, celebrate excellence and innovation across Welsh business. Judged through a rigorous, merit-based process, the awards showcase organisations that are raising standards and making a lasting impact.
Press Contact:
Gill Pharmaceuticals Ltd / ICONA UK
ask@iconauk.com
www.iconauk.com
